Table 4.
No.1 | OR | 95% CI
|
||
---|---|---|---|---|
Jurisdiction | ||||
Northern Europe | 681 | 0.60 | 0.50 | 0.72 |
Western Europe | 1,595 | 1.57 | 1.36 | 1.81 |
Southern Europe | 1,848 | 1 | ||
Eastern Europe | 477 | 0.16 | 0.12 | 0.20 |
US | 1,185 | 0.80 | 0.69 | 0.94 |
Age (years) | ||||
15–39 | 244 | 1.33 | 0.99 | 1.78 |
40–49 | 1,039 | 1.44 | 1.21 | 1.70 |
50–59 | 1,558 | 1.38 | 1.19 | 1.60 |
60–69 | 1,614 | 1 | ||
70–99 | 1,331 | 0.48 | 0.41 | 0.56 |
Tumour size | ||||
Less than 5mm (T1a) | 380 | 0.94 | 0.75 | 1.17 |
5–10mm (T1b) | 1,650 | 1.31 | 1.16 | 1.48 |
>10mm, up to 20mm (T1c) | 3,756 | 1 | ||
|
Number of women with early node-negative disease who were operated, with information on tumour size available